Lista de obras -

(1-34) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers

artículo científico publicado en 2012

A Patient With CKD Develops Cholestatic Liver Injury During a Clinical Trial

artículo científico publicado en 2017

A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD

scientific article published on 05 July 2019

A Simple Equation to Estimate Urinary Flow Rate Using Urine Creatinine

artículo científico publicado en 2020

A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease

scientific article published on 15 July 2009

Acid Load and Phosphorus Homeostasis in CKD.

artículo científico publicado en 2017

Association of Educational Attainment With Incidence of CKD in Young Adults

artículo científico publicado en 2020

Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study

artículo científico publicado en 2016

Association of Fitness With Racial Differences in Chronic Kidney Disease

artículo científico publicado en 2019

Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy

artículo científico publicado en 2012

Associations of FGF23 With Change in Bone Mineral Density and Fracture Risk in Older Individuals

artículo científico publicado en 2015

Associations of Fenofibrate Therapy With Incidence and Progression of CKD in Patients With Type 2 Diabetes

scientific article published on 18 September 2018

Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease

artículo científico publicado en 2012

Change in estimated glomerular filtration rate and fracture risk in the Action to Control Cardiovascular Risk in Diabetes Trial

artículo científico publicado en 2015

Chicago supermarket data and food access analytics in census tract shapefiles for 2007-2014

artículo científico publicado en 2018

Continued Search for Therapies to Favorably Modify Phosphate and FGF23 Levels in CKD.

artículo científico publicado en 2017

DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease

Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.

artículo científico

Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients on Maintenance Hemodialysis

scientific article published on 03 December 2020

Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort

artículo científico publicado en 2011

Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference

artículo científico publicado en 2020

Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease

artículo científico publicado en 2012

Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD.

artículo científico publicado en 2017

Effects of ferric carboxymaltose on markers of mineral and bone metabolism: a single-center prospective observational study of women with iron deficiency

artículo científico publicado en 2020

FGF23 (Fibroblast Growth Factor-23) and Incident Hypertension in Young and Middle-Aged Adults: The CARDIA Study

artículo científico publicado en 2018

FGF23 induces left ventricular hypertrophy

artículo científico publicado en 2011

FGF23 or PTH: which comes first in CKD ?

artículo científico publicado en 2010

Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease

scientific article published on 30 August 2019

Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study

artículo científico publicado en 2019

Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study

artículo científico

Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study

artículo científico publicado en 2016

Fibroblast Growth Factor 23 and Exercise Capacity in Heart Failure with Preserved Ejection Fraction

scientific article published on 06 October 2020

Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease

artículo científico publicado en 2017

Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study

artículo científico publicado en 2020

Fibroblast Growth Factor-23, Heart Failure Risk, and Renin-Angiotensin-Aldosterone-System Blockade in Hypertension: The MESA Study

scientific article published on 01 January 2019

Fibroblast growth factor 23 and Inflammation in CKD

artículo científico publicado en 2012

Fibroblast growth factor 23 and incident CKD in type 2 diabetes.

artículo científico publicado en 2014

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

artículo científico publicado en 2011

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease ⬇️

artículo científico publicado el 9 de marzo de 2011

Fibroblast growth factor 23 is not associated with and does not induce arterial calcification

artículo científico publicado en 2013

Fibroblast growth factor-23 and cardiovascular events in CKD.

artículo científico publicado en 2013

Food Access, Chronic Kidney Disease, and Hypertension in the U.S

artículo científico publicado en 2015

Genetic African Ancestry and Markers of Mineral Metabolism in CKD.

artículo científico publicado en 2016

Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program

artículo científico publicado en 2012

Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey

artículo científico publicado en 2010

Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes

scientific article published on 24 May 2018

Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease

artículo científico publicado en 2016

Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production

artículo científico publicado en 2015

Inflammatory Markers and Incidence of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study

scientific article published on 01 November 2019

KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

artículo científico publicado en 2017

KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.

artículo científico

Klotho variants and chronic hemodialysis mortality

artículo científico publicado en 2009

Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study

artículo científico publicado en 2019

Longitudinal FGF23 Trajectories and Mortality in Patients with CKD.

artículo científico publicado en 2017

Low socioeconomic status associates with higher serum phosphate irrespective of race

artículo científico publicado en 2010

Microbiome and Cardiovascular Disease in CKD

artículo científico publicado en 2018

Mineral bone disease in autosomal dominant polycystic kidney disease

artículo científico publicado en 2020

Mineral metabolites and CKD progression in African Americans

artículo científico publicado en 2012

Multicenter Study Evaluating Intrarenal Oxygenation and Fibrosis Using Magnetic Resonance Imaging in Individuals With Advanced CKD

artículo científico publicado en 2018

New susceptibility loci associated with kidney disease in type 1 diabetes

artículo científico publicado en 2012

Partial answers from partial Klotho deficiency

artículo científico publicado en 2012

Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study

artículo científico publicado en 2015

Phosphorus binders and survival on hemodialysis

artículo científico publicado en 2008

Plasma gelsolin and circulating actin correlate with hemodialysis mortality

artículo científico publicado en 2009

Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD

artículo científico publicado en 2008

Racial Differences in the Associations Between Food Insecurity and Fibroblast Growth Factor 23 in the Coronary Artery Risk Development in Young Adults Study

scientific article published on 05 March 2020

Racial differences in postprandial mineral ion handling in health and in chronic kidney disease

artículo científico publicado en 2010

Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort

artículo científico publicado en 2017

Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.

artículo científico publicado en 2015

Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study

artículo científico publicado en 2019

Serum Calcification Propensity and Clinical Events in CKD

scientific article published on 28 October 2019

Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study

artículo científico publicado en 2019

Serum Phosphate and Retinal Microvascular Changes: The Multi-Ethnic Study of Atherosclerosis and the Beaver Dam Eye Study

artículo científico publicado en 2017

Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD

artículo científico publicado en 2019

Sleep disordered breathing and fibroblast growth factor 23 in the Hispanic Community Health Study/Study of Latinos

scientific article published on 03 July 2018

Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks

artículo científico publicado en 2017

Systematic integrated analysis of genetic and epigenetic variation in diabetic kidney disease

artículo científico publicado en 2020

The phosphate bucket list.

artículo científico publicado en 2018

Tip-toeing toward the finish line

artículo científico publicado en 2014

Urban foodscape trends: Disparities in healthy food access in Chicago, 2007-2014

artículo científico publicado en 2018

Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.

artículo científico publicado en 2017

Vitamin D Deficiency, Inflammation, and Albuminuria in Chronic Kidney Disease: Complex Interactions ⬇️

artículo científico publicado el 3 de septiembre de 2010

Vitamin D Metabolic Ratio and Risks of Death and CKD Progression

artículo científico publicado en 2019

Lista de obras de

(1-34) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers

A Patient With CKD Develops Cholestatic Liver Injury During a Clinical Trial

A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD

A Simple Equation to Estimate Urinary Flow Rate Using Urine Creatinine

A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease

Acid Load and Phosphorus Homeostasis in CKD.

Association of Educational Attainment With Incidence of CKD in Young Adults

Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study

Association of Fitness With Racial Differences in Chronic Kidney Disease

Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy

Associations of FGF23 With Change in Bone Mineral Density and Fracture Risk in Older Individuals

Associations of Fenofibrate Therapy With Incidence and Progression of CKD in Patients With Type 2 Diabetes

Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease

Change in estimated glomerular filtration rate and fracture risk in the Action to Control Cardiovascular Risk in Diabetes Trial

Chicago supermarket data and food access analytics in census tract shapefiles for 2007-2014

Continued Search for Therapies to Favorably Modify Phosphate and FGF23 Levels in CKD.

DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease

Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.

Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients on Maintenance Hemodialysis

Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort

Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference

Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease

Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD.

Effects of ferric carboxymaltose on markers of mineral and bone metabolism: a single-center prospective observational study of women with iron deficiency

FGF23 (Fibroblast Growth Factor-23) and Incident Hypertension in Young and Middle-Aged Adults: The CARDIA Study

FGF23 induces left ventricular hypertrophy

FGF23 or PTH: which comes first in CKD ?

Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease

Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study

Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study

Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study

Fibroblast Growth Factor 23 and Exercise Capacity in Heart Failure with Preserved Ejection Fraction

Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease

Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study

Fibroblast Growth Factor-23, Heart Failure Risk, and Renin-Angiotensin-Aldosterone-System Blockade in Hypertension: The MESA Study

Fibroblast growth factor 23 and Inflammation in CKD

Fibroblast growth factor 23 and incident CKD in type 2 diabetes.

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease ⬇️

Fibroblast growth factor 23 is not associated with and does not induce arterial calcification

Fibroblast growth factor-23 and cardiovascular events in CKD.

Food Access, Chronic Kidney Disease, and Hypertension in the U.S

Genetic African Ancestry and Markers of Mineral Metabolism in CKD.

Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program

Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey

Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes

Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease

Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production

Inflammatory Markers and Incidence of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study

KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.

Klotho variants and chronic hemodialysis mortality

Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study

Longitudinal FGF23 Trajectories and Mortality in Patients with CKD.

Low socioeconomic status associates with higher serum phosphate irrespective of race

Microbiome and Cardiovascular Disease in CKD

Mineral bone disease in autosomal dominant polycystic kidney disease

Mineral metabolites and CKD progression in African Americans

Multicenter Study Evaluating Intrarenal Oxygenation and Fibrosis Using Magnetic Resonance Imaging in Individuals With Advanced CKD

New susceptibility loci associated with kidney disease in type 1 diabetes

Partial answers from partial Klotho deficiency

Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study

Phosphorus binders and survival on hemodialysis

Plasma gelsolin and circulating actin correlate with hemodialysis mortality

Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD

Racial Differences in the Associations Between Food Insecurity and Fibroblast Growth Factor 23 in the Coronary Artery Risk Development in Young Adults Study

Racial differences in postprandial mineral ion handling in health and in chronic kidney disease

Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort

Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.

Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study

Serum Calcification Propensity and Clinical Events in CKD

Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study

Serum Phosphate and Retinal Microvascular Changes: The Multi-Ethnic Study of Atherosclerosis and the Beaver Dam Eye Study

Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD

Sleep disordered breathing and fibroblast growth factor 23 in the Hispanic Community Health Study/Study of Latinos

Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks

Systematic integrated analysis of genetic and epigenetic variation in diabetic kidney disease

The phosphate bucket list.

Tip-toeing toward the finish line